Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
DocGo Inc (NASDAQ: DCGO) closed the day trading at $1.39 down -4.79% from the previous closing price of $1.46. In other words, the price has decreased by -$4.79 from its previous closing price. On the day, 0.67 million shares were traded. DCGO stock price reached its highest trading level at $1.46 during the session, while it also had its lowest trading level at $1.37.
Ratios:
For a better understanding of DCGO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.63. For the most recent quarter (mrq), Quick Ratio is recorded 2.36 and its Current Ratio is at 2.36. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.07.
On February 28, 2025, Deutsche Bank Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $5 to $2.85.
On August 18, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on August 18, 2023, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 ’25 when Burdiek Michael J bought 10,000 shares for $1.33 per share. The transaction valued at 13,300 led to the insider holds 641,560 shares of the business.
Burdiek Michael J bought 15,000 shares of DCGO for $21,450 on May 15 ’25. The Director now owns 631,560 shares after completing the transaction at $1.43 per share. On May 14 ’25, another insider, Klasko Stephen K. M.D., who serves as the Director of the company, bought 15,000 shares for $1.49 each. As a result, the insider paid 22,350 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 135953312 and an Enterprise Value of 82694536. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at 0.19 whereas that against EBITDA is -6.094.
Stock Price History:
The Beta on a monthly basis for DCGO is 0.97, which has changed by -0.5887574 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $5.68, while it has fallen to a 52-week low of $1.23. The 50-Day Moving Average of the stock is -8.80%, while the 200-Day Moving Average is calculated to be -46.74%.
Shares Statistics:
Over the past 3-months, DCGO traded about 474.76K shares per day on average, while over the past 10 days, DCGO traded about 390940 shares per day. A total of 97.76M shares are outstanding, with a floating share count of 84.92M. Insiders hold about 13.18% of the company’s shares, while institutions hold 47.77% stake in the company. Shares short for DCGO as of 1756425600 were 4044233 with a Short Ratio of 9.40, compared to 1753920000 on 4650120. Therefore, it implies a Short% of Shares Outstanding of 4044233 and a Short% of Float of 4.22.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.4 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.17 and -$1.17 for the fiscal current year, implying an average EPS of -$1.17. EPS for the following year is -$0.74, with 1.0 analysts recommending between -$0.74 and -$0.74.
Revenue Estimates
7 analysts predict $69.96M in revenue for the current quarter. It ranges from a high estimate of $73.36M to a low estimate of $67.65M. As of the current estimate, DocGo Inc’s year-ago sales were $138.68MFor the next quarter, 7 analysts are estimating revenue of $71.57M. There is a high estimate of $75.18M for the next quarter, whereas the lowest estimate is $68.51M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $323.46M, while the lowest revenue estimate was $315.01M, resulting in an average revenue estimate of $317.98M. In the same quarter a year ago, actual revenue was $616.56MBased on 7 analysts’ estimates, the company’s revenue will be $316.56M in the next fiscal year. The high estimate is $336.25M and the low estimate is $297.6M.
